Subscribe

Spotlight -

Frank Behrens, MD

Frank Behrens, MD, Professor of Translational Rheumatology, Goethe-University Frankfurt

Professor of Translational Rheumatology, Immunology, and Inflammation Medicine and Head of the Inflammation Clinic (Rheumatology, Inflammatory Skin Diseases, Inflammatory Bowel Diseases) at the Goethe-University Hospital and a Deputy Director of the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP) at the Goethe-University Frankfurt

Articles by Frank Behrens, MD

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD

ByFrank Behrens, MD

July 15th 2026

KEEPsAKE 1 long-term data confirm sustained MDA responses, structural protection in nearly 9 in 10 patients, and a cardiovascular safety signal that may favor IL-23 inhibition over JAK inhibitors.

AgAIN: Secukinumab Outperforms Ustekinumab in Post-TNFi Psoriatic Arthritis, With Frank Behrens, MD

AgAIN: Secukinumab Outperforms Ustekinumab in Post-TNFi Psoriatic Arthritis, With Frank Behrens, MD

ByFrank Behrens, MD

October 27th 2025

Behrens discussed strong data supporting secukinumab's use over ustekinumab post-TNF inhibitor in PsA.

Latest Updated Articles

AgAIN: Secukinumab Outperforms Ustekinumab in Post-TNFi Psoriatic Arthritis, With Frank Behrens, MD
October 27th 2025

Trending on Rheumatology Live

Belimumab Nearly Doubled Non-GC Remission and LLDAS Rates in SLE Post-Hocs

Risankizumab’s Durable Efficacy, Safety in PsA, With Frank Behrens, MD

Allocetra Immunotherapy Gets RMAT Designation for Age-Related Knee Osteoarthritis